MAPT and Alzheimer disease: Okadaic acid, acting as a phosphatase inhibitor, induces hyperphosphorylation and accumulation of neurofilaments in the cells, thereby mirroring the hyperphosphorylated, tau-induced neurodegeneration observed in AD brain [55,56].